Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Antimicrobial (Drug) Resistance Quick Facts

methicillin-resistant Staphylococcus aureus bacteria
Scanning electron micrograph depicting methicillin-resistant Staphylococcus aureus bacteria with a human white cell.
Credit: NIAID
  • Many infectious diseases are increasingly difficult to treat because of antimicrobial-resistant organisms, including HIV infection, staphylococcal infection, tuberculosis, influenza, gonorrhea, candida infection, and malaria.
  • Between 5 and 10 percent of all hospital patients develop an infection. About 90,000 of these patients die each year as a result of their infection, up from 13,300 patient deaths in 1992.
  • According to the Centers for Disease Control and Prevention (CDC) (April 2011), antibiotic resistance in the United States costs an estimated $20 billion a year in excess health care costs, $35 billion in other societal costs and more than 8 million additional days that people spend in the hospital.
  • People infected with antimicrobial-resistant organisms are more likely to have longer hospital stays and may require more complicated treatment.
  • The Antibiotic Resistance Threats in the United States, 2013 report from CDC gives a first-ever snapshot of the burden and threats posed by the antibiotic-resistant germs having the most impact on human health.

Last Updated March 20, 2014